NCT07762326Not yet recruiting
Effect of Artificial Intelligence Based Cognitive Training on Sleep Disorders and Quality of Life in Patients With Multiple Sclerosis
Source: ClinicalTrials.gov · Last updated 13 Aug 2026
Brief summary (registry, in English)
this study will be conducted to investigate the effect of artificial intelligence (AI) based cognitive training on sleep disorders and quality of life in patients with multiple sclerosis.
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 40 (estimated)
- First submitted
- 5 Aug 2026
- Start date
- 20 Aug 2026
- Primary completion date
- 30 Mar 2027
- Lead sponsor
- Cairo University
- Diseases
- Multiple sclerosis
- NCT number
- NCT07762326
What you commit to
- Study type: Interventional
- Planned participants: 40
- From 20 Aug 2026 to the primary completion date, 30 Mar 2027
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Cardiovascular problems (unstable angina, recent myocardial infarction within the last three months, congestive heart failure, significant heart valve dysfunction, or unstable hypertension) or pulmonary disorders.
- Sensory impairment caused by other diseases except the MS such as diabetes mellitus.
Other
- Mechanical or neuromascular problems.
- Auditory problems.
Who the study is looking for
- Patient's age ranges from 25-40 years.
- Patient with EDSS not more than 5.
- Patients who have no relapses for the previous three months.
- Patients with sufficient cognitive abilities that enables them to understand and follow
- instructions with a score more than 24 according to the Mini-Mental State Examination scale
Age in the registry: 25 years to 40 years · Sex: All · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.